Schedule 13G ownership disclosure

QUOIN PHARMACEUTICALS LTD

Ordinary Shares · CUSIP: 74907L409

Event date: 2026-01-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Stonepine Capital Management, LLC

    Shares: 3,271,100.00 · Class: 10.6%

  • Stonepine Capital, L.P.

    Shares: 3,271,100.00 · Class: 10.6%

  • Stonepine GP, LLC

    Shares: 3,271,100.00 · Class: 10.6%

  • Jon M. Plexico

    Shares: 3,271,100.00 · Class: 10.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-26-000065
Form type
SCHEDULE 13G/A
Filer
Quoin Pharmaceuticals, Ltd.
CIK
CIK 1671502
Filed
Feb 02, 2026
Reporting period
Jan 29, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub